| Avelumab studied in …STUDIED_INderived200 of 235show all (up to 200) |
|---|
| → studied in | NCT02767063Phase 1/Phase 2 · active not recruiting Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW) · 235 trials list this drug (51 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03076554Phase 2 · active not recruiting A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy · 235 trials list this drug (51 active) | — | — | Thymoma,Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327530Phase 2 · active not recruiting A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley) · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071236Phase 1/Phase 2 · suspended Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy · 235 trials list this drug (51 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03573648Phase 2 · active not recruiting Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer · 235 trials list this drug (51 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03815643Phase 3 · active not recruiting Avelumab Program Rollover Study · 235 trials list this drug (51 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04387084Phase 1 · active not recruiting Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy · 235 trials list this drug (51 active) | — | — | Malignant Skin Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05267626Phase 1/Phase 2 · recruiting Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer · 235 trials list this drug (51 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Cutaneous Melanoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05327686Phase 2 · recruiting Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial · 235 trials list this drug (51 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05396833Phase 1 · completed Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320) · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03147287Phase 2 · active not recruiting Palbociclib After CDK and Endocrine Therapy (PACE) · 235 trials list this drug (51 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03964532Phase 1/Phase 2 · active not recruiting TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer · 235 trials list this drug (51 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03547973Phase 2 · active not recruiting Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04068194Phase 1/Phase 2 · active not recruiting Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies · 235 trials list this drug (51 active) | — | — | Malignant Solid Neoplasm,Malignant Gallbladder Neoplasm,Cholangiocarcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04360941Phase 1 · active not recruiting PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast Cancer · 235 trials list this drug (51 active) | — | — | Malignant Breast Neoplasm,HER2-Positive Breast Carcinoma,Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06228066Phase 2 · recruiting Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER) · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03440567Phase 1 · completed Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma · 235 trials list this drug (51 active) | — | — | Diffuse Large B-Cell Lymphoma,Mantle Cell Lymphoma,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06412848completed JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05947500Phase 2 · active not recruiting Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial · 235 trials list this drug (51 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05081180Phase 1 · terminated Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors · 235 trials list this drug (51 active) | — | — | Central Nervous System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02912572Phase 2 · active not recruiting Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer · 235 trials list this drug (51 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03006848Phase 2 · completed A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma · 235 trials list this drug (51 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03414658Phase 2 · active not recruiting The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer · 235 trials list this drug (51 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03744793Phase 2 · active not recruiting Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma,Invasive Bladder Micropapillary Urothelial Carcinoma,Invasive Bladder Plasmacytoid Urothelial Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02813135Phase 1/Phase 2 · recruiting European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors · 235 trials list this drug (51 active) | — | — | Childhood Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04328844Phase 1 · active not recruiting A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers · 235 trials list this drug (51 active) | — | — | Adult Solid Neoplasm,Uveal Melanoma,Adult Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03391479Phase 2 · active not recruiting A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy · 235 trials list this drug (51 active) | — | — | Malignant Neoplasm,Malignant Penile Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059522Phase 3 · active not recruiting Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing · 235 trials list this drug (51 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma,Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07110038Phase 2 · recruiting DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma · 235 trials list this drug (51 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03271372Phase 3 · active not recruiting Adjuvant Avelumab in Merkel Cell Cancer · 235 trials list this drug (51 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05092958Phase 3 · active not recruiting Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study · 235 trials list this drug (51 active) | — | — | Renal Pelvis and Ureter Carcinoma,Bladder Urothelial Carcinoma,Malignant Bladder Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266912Phase 1/Phase 2 · active not recruiting Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors · 235 trials list this drug (51 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03944941Phase 2 · active not recruiting Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer · 235 trials list this drug (51 active) | — | — | Malignant Skin Neoplasm,Skin Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06225596Phase 2 · active not recruiting Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) · 235 trials list this drug (51 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03324282Phase 2 · terminated First-line Gemcitabine/Cisplatin +/- Avelumab in Locally Advanced or Metastatic Bladder Carcinoma · 235 trials list this drug (51 active) | — | — | Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03494322Phase 2 · completed EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer · 235 trials list this drug (51 active) | — | — | Malignant Head and Neck Neoplasm,Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06204614early Phase 1 · enrolling by invitation Drug Screening Using IMD in Bladder Cancer · 235 trials list this drug (51 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06892860Phase 2 · recruiting Comparing 3 vs 6 Cycles of Platinum-based Chemotherapy Prior to Maintenance Avelumab in Advanced Urothelial Cancer · 235 trials list this drug (51 active) | — | — | Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03217747Phase 1/Phase 2 · active not recruiting Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies · 235 trials list this drug (51 active) | — | — | Malignant Solid Neoplasm,Malignant Prostate Neoplasm,Prostate Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04902040Phase 1/Phase 2 · terminated Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies · 235 trials list this drug (51 active) | — | — | Malignant Solid Neoplasm,Melanoma,Malignant Lung Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03971409Phase 2 · active not recruiting Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer · 235 trials list this drug (51 active) | — | — | Malignant Breast Neoplasm,Breast Carcinoma,Invasive Breast Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291885Phase 2 · active not recruiting Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma · 235 trials list this drug (51 active) | — | — | Neuroendocrine Tumor,Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04841148Phase 2 · recruiting Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer · 235 trials list this drug (51 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04792073Phase 2 · active not recruiting Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma · 235 trials list this drug (51 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04822350completed A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04261855Phase 1/Phase 2 · active not recruiting Targeted Therapy and Avelumab in Merkel Cell Carcinoma · 235 trials list this drug (51 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04637594Phase 3 · active not recruiting Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma,Bladder Urothelial Carcinoma,Urethral Urothelial Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04004442Phase 1 · active not recruiting Avelumab in Combination With AVB-S6-500 in Patients With Advanced Urothelial Carcinoma · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03719768Phase 1 · completed Avelumab With Radiotherapy in Patients With Leptomeningeal Disease · 235 trials list this drug (51 active) | — | — | Leptomeningeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03252938Phase 1 · active not recruiting Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors · 235 trials list this drug (51 active) | — | — | Solid Neoplasm,Urothelial Carcinoma,Peritoneal Carcinomatosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04848519Phase 2 · active not recruiting Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma,Bladder Urothelial Carcinoma,Malignant Bladder Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03260023Phase 1/Phase 2 · active not recruiting Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers · 235 trials list this drug (51 active) | — | — | Human Papillomavirus-Related Carcinoma,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,Human Papillomavirus-Related Cervical Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06939036Phase 1/Phase 2 · terminated Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 ) · 235 trials list this drug (51 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04701918Phase 2 · completed Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06518564Phase 2 · recruiting Avelumab and M1774 in ARID1A-mutated Endometrial Cancer · 235 trials list this drug (51 active) | — | — | Endometrial Carcinoma,Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05419362Phase 2 · completed GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer · 235 trials list this drug (51 active) | — | — | Malignant Gastric Neoplasm,Gastroesophageal Junction Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02926196Phase 3 · completed Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab · 235 trials list this drug (51 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04188119Phase 2 · withdrawn A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer · 235 trials list this drug (51 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03575013Phase 1 · completed A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05366725completed A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07225374Phase 2 · recruiting Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC · 235 trials list this drug (51 active) | — | — | Renal Pelvis and Ureter Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03747419Phase 2 · terminated Avelumab and Radiation in Muscle-Invasive Bladder Cancer · 235 trials list this drug (51 active) | — | — | Bladder Neoplasm,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06557278Phase 2 · withdrawn Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer · 235 trials list this drug (51 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04887831Phase 2 · terminated Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma,Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242238Phase 1 · completed Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas · 235 trials list this drug (51 active) | — | — | Sarcoma,High Grade Sarcoma,Dedifferentiated Liposarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05222932Phase 1 · active not recruiting Oncolytic Adenovirus TILT-123 and Avelumab for Treatment of Solid Tumors Refractory to or Progressing After Anti-PD(L)1 · 235 trials list this drug (51 active) | — | — | Melanoma,Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02684006Phase 3 · completed A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) · 235 trials list this drug (51 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04341181Phase 2 · recruiting ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling · 235 trials list this drug (51 active) | — | — | Neoplasm,Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03186326Phase 2 · completed Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic Cancer · 235 trials list this drug (51 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03357757Phase 2 · completed Avelumab With Valproic Acid in Virus-associated Cancer · 235 trials list this drug (51 active) | — | — | Cervical Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05687721Phase 1/Phase 2 · withdrawn Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03826589NA · completed Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy · 235 trials list this drug (51 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03047473Phase 2 · completed Avelumab in Patients With Newly Diagnosed Glioblastoma Multiforme · 235 trials list this drug (51 active) | — | — | Brain Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02999087Phase 3 · active not recruiting Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH) · 235 trials list this drug (51 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05217069Phase 2 · completed FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03724890Phase 1 · completed Study of Avelumab-M3814 Combinations · 235 trials list this drug (51 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03498378Phase 1 · active not recruiting Avelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · 235 trials list this drug (51 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05431777completed A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05650164completed Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART2) · 235 trials list this drug (51 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03893903Phase 1 · completed AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma · 235 trials list this drug (51 active) | — | — | Malignant Glioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03747484Phase 1/Phase 2 · terminated Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03674424Phase 2 · completed Avelumab as Neoadjuvant Therapy in Subjects With Urothelial Muscle Invasive Bladder Cancers (AURA Trial) · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04322643Phase 2 · terminated Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03169764Phase 1/Phase 2 · withdrawn QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy · 235 trials list this drug (51 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03169790Phase 1/Phase 2 · withdrawn QUILT-3.052: NANT Non-Hodgkin Lymphoma (NHL) Vaccine: Combination Immunotherapy in Subjects With Relapsed CD20-positive NHL · 235 trials list this drug (51 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03167164Phase 1/Phase 2 · withdrawn QUILT-3.045: NANT Merkel Cell Carcinoma (MCC) Vaccine: Combination Immunotherapy in Subjects With MCC Who Have Progressed on or After PD-L1 Therapy · 235 trials list this drug (51 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03167177Phase 1/Phase 2 · withdrawn QUILT-3.046: NANT Melanoma Vaccine: Combination Immunotherapy in Subjects With Melanoma Who Have Progressed On or After Chemotherapy and PD-1/PD-L1 Therapy · 235 trials list this drug (51 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03169738Phase 1/Phase 2 · withdrawn QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03169777Phase 1/Phase 2 · withdrawn QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC · 235 trials list this drug (51 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03175666Phase 1/Phase 2 · withdrawn QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy · 235 trials list this drug (51 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03197571Phase 1/Phase 2 · withdrawn QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03197584Phase 1/Phase 2 · withdrawn QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) Therapy · 235 trials list this drug (51 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03554109Phase 2 · withdrawn QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine · 235 trials list this drug (51 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03563144Phase 2 · withdrawn QUILT-3.088: NANT Pancreatic Cancer Vaccine · 235 trials list this drug (51 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03574649Phase 2 · withdrawn QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03647423Phase 1/Phase 2 · withdrawn QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma. · 235 trials list this drug (51 active) | — | — | Malignant Neoplasm,Chordoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03636503Phase 1 · terminated Rituximab + Immunotherapy in Follicular Lymphoma · 235 trials list this drug (51 active) | — | — | Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02576574Phase 3 · completed Avelumab in First-line NSCLC (JAVELIN Lung 100) · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04215146Phase 2 · active not recruiting A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study · 235 trials list this drug (51 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04562441Phase 2 · completed NPC - AXEL Study : Axitinib-Avelumab · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513951Phase 2 · completed AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients · 235 trials list this drug (51 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04682587completed To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma · 235 trials list this drug (51 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04871529Phase 2 · terminated Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL) · 235 trials list this drug (51 active) | — | — | Invasive Renal Pelvis and Ureter Urothelial Carcinoma,Malignant Bladder Neoplasm,Muscle Invasive Bladder Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04068831Phase 2 · completed Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma · 235 trials list this drug (51 active) | — | — | Renal Cell Carcinoma,Fumarate Hydratase-Deficient Renal Cell Carcinoma,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03278379Phase 2 · completed Avelumab in G2-3 NET · 235 trials list this drug (51 active) | — | — | Neuroendocrine Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03329248Phase 1/Phase 2 · terminated QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy · 235 trials list this drug (51 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03563157Phase 1/Phase 2 · terminated QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine · 235 trials list this drug (51 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03845166Phase 1 · active not recruiting A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors · 235 trials list this drug (51 active) | — | — | Malignant Neoplasm,Hormone Receptor-Positive Breast Carcinoma,Malignant Colorectal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03990571Phase 2 · completed Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma · 235 trials list this drug (51 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06424717Phase 2 · withdrawn Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder) · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02994953Phase 1 · terminated A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12) · 235 trials list this drug (51 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04173507Phase 2 · completed Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial) · 235 trials list this drug (51 active) | — | — | Malignant Lung Neoplasm,Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02875613Phase 2 · terminated Avelumab for Recurrent/Metastatic Nasopharyngeal Cancer · 235 trials list this drug (51 active) | — | — | Malignant Nasopharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03586869Phase 1/Phase 2 · terminated QUILT-3.080: NANT Pancreatic Cancer Vaccine · 235 trials list this drug (51 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03050554Phase 1/Phase 2 · terminated SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC) · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03387085Phase 1/Phase 2 · terminated QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy. · 235 trials list this drug (51 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03853317Phase 2 · terminated QUILT-3.063: A Study of N-803, haNK and Avelumab in Patients With Merkel Cell Carcinoma That Has Progressed After Checkpoint Therapy · 235 trials list this drug (51 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03387111Phase 1/Phase 2 · terminated QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed · 235 trials list this drug (51 active) | — | — | Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02554812Phase 1/Phase 2 · terminated A Study Of Avelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley) · 235 trials list this drug (51 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03244176early Phase 1 · unknown Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study · 235 trials list this drug (51 active) | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03046953Phase 2 · completed Avelumab in Relapsed and Refractory Peripheral T-cell Lymphoma · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03770455Phase 2 · terminated Avelumab Plus 2nd-generation ADT in African American Subjects With mCRPC · 235 trials list this drug (51 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03200587Phase 1 · completed Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC) · 235 trials list this drug (51 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03451825Phase 1 · terminated Phase I/II Study of Avelumab in Pediatric Cancer Participants · 235 trials list this drug (51 active) | — | — | Central Nervous System Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03136406Phase 1/Phase 2 · terminated QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy · 235 trials list this drug (51 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03387098Phase 1/Phase 2 · terminated QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy · 235 trials list this drug (51 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03915405Phase 1 · terminated KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03472560Phase 2 · terminated A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF) · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03558139Phase 1 · completed Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy · 235 trials list this drug (51 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02603432Phase 3 · completed A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02155647Phase 2 · completed Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200) · 235 trials list this drug (51 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04396223Phase 1/Phase 2 · recruiting Avelumab and Methotrexate in in Low-risk Gestational Trophoblastic Neoplasias as First Line Treatment · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05700344completed SOGUG-AVELUMAB_RWD · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03892642Phase 1/Phase 2 · completed Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer · 235 trials list this drug (51 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03891238Phase 2 · completed Avelumab as Single Agent in Metastatic or Locally Advanced Urothelial Cancer in Patients Unfit for Cisplatin. The ARIES Study · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05291156Phase 2 · unknown CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy · 235 trials list this drug (51 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02915523Phase 1/Phase 2 · completed Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer · 235 trials list this drug (51 active) | — | — | Malignant Peritoneal Neoplasm,Malignant Fallopian Tube Neoplasm,Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03783936Phase 2 · completed Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas · 235 trials list this drug (51 active) | — | — | Esophageal Adenocarcinoma,Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03386929Phase 1/Phase 2 · terminated Survival Prolongation by Rationale Innovative Genomics · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03617666Phase 2 · unknown Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study · 235 trials list this drug (51 active) | — | — | Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05012865completed Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART) · 235 trials list this drug (51 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05394493completed An Observational Chart Review Study To Describe The Real-World Outcomes And Use Of Avelumab In Combination With Axitinib For Treatment Of Patients With aRCC In The UK · 235 trials list this drug (51 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03861403Phase 1 · terminated A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors · 235 trials list this drug (51 active) | — | — | Solid Neoplasm,Platinum-Resistant Ovarian Carcinoma,Castration-Resistant Prostate Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04555603withdrawn Axitinib Therapy Management Study · 235 trials list this drug (51 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03409458Phase 1/Phase 2 · completed A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03503786Phase 2 · unknown Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer · 235 trials list this drug (51 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03941262Phase 1 · completed Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy · 235 trials list this drug (51 active) | — | — | Malignant Neoplasm,Solid Neoplasm,Adult Solid Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03399552Phase 1/Phase 2 · completed Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma · 235 trials list this drug (51 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03854799Phase 2 · completed Immunotherapy In Locally Advanced Rectal Cancer · 235 trials list this drug (51 active) | — | — | Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03565991Phase 2 · terminated Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551885Phase 1 · terminated FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors · 235 trials list this drug (51 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05600127Phase 2 · recruiting Chemotherapy and Sequential Immunotherapy for Locally Advanced Urothelial Cancer · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176288Phase 2 · withdrawn Avelumab, Palbociclib and Axitinib in Advanced RCC · 235 trials list this drug (51 active) | — | — | Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03390296Phase 1/Phase 2 · completed OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia · 235 trials list this drug (51 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04601402Phase 1 · completed GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy · 235 trials list this drug (51 active) | — | — | Solid Neoplasm,Head and Neck Squamous Cell Carcinoma,Lung Non-Small Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05568407terminated A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer · 235 trials list this drug (51 active) | — | — | Malignant Bladder Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02580058Phase 3 · completed A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) · 235 trials list this drug (51 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584634Phase 1/Phase 2 · terminated Study to Evaluate Safety, Efficacy, Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC. (Javelin Lung 101) · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03267836Phase 1 · terminated Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma · 235 trials list this drug (51 active) | — | — | Meningioma,Adult Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03568097Phase 2 · unknown Immunotherapy in Combination With Chemotherapy in Small-cell Lung Cancer · 235 trials list this drug (51 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05249569Phase 2 · terminated Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular Carcinoma · 235 trials list this drug (51 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03774901Phase 2 · unknown Maintenance Avelumab Immunotherapy in Patients With Locally Advanced or Metastatic Squamous Cell Penile Carcinoma · 235 trials list this drug (51 active) | — | — | Penile Neoplasm,Penile Squamous Cell Carcinoma,Malignant Penile Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05107427Phase 2 · withdrawn Study of MRx0518 and Avelumab in Patients With Urothelial Carcinoma · 235 trials list this drug (51 active) | — | — | Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03299660Phase 2 · completed Avelumab With Chemoradiation in Locally Advanced Rectal Cancer · 235 trials list this drug (51 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03787602Phase 1/Phase 2 · unknown Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma · 235 trials list this drug (51 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03617913Phase 2 · completed Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer · 235 trials list this drug (51 active) | — | — | Malignant Bladder Neoplasm,Malignant Ureter Neoplasm,Malignant Urethral Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03750071Phase 1/Phase 2 · unknown VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma · 235 trials list this drug (51 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03827044Phase 3 · terminated Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer · 235 trials list this drug (51 active) | — | — | Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03174405Phase 2 · completed Avelumab and Cetuximab in Combination With FOLFOX in Patients With Previously Untreated Metastatic Colorectal Cancer - The Phase II AVETUX-CRC Trial. · 235 trials list this drug (51 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04571632Phase 2 · unknown Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors · 235 trials list this drug (51 active) | — | — | Solid Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03905135Phase 1 · completed Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies · 235 trials list this drug (51 active) | — | — | Anaplastic Large Cell Lymphoma,Mycosis Fungoides,Sezary Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03483883Phase 1 · terminated Avelumab/Gemcitabine in Sarcomatoid RCC · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03491345Phase 2 · unknown K-Basket, Avelumab, Biomarker-driven, Advanced Solid Tumor · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04065555early Phase 1 · completed Intratumoral Microdosing of TAK-981 in Head and Neck Cancer · 235 trials list this drug (51 active) | — | — | Malignant Head and Neck Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03502681Phase 1 · terminated A Study Combining Eribulin Mesylate With Avelumab in Cisplatin Ineligible Metastatic Urothelial Cell Cancer Patients · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02968940Phase 2 · completed Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma · 235 trials list this drug (51 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02625610Phase 3 · completed Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100) · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03717155Phase 2 · completed Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03270176Phase 1 · completed A Dose-Finding Study of the Second Mitochondrial Activator of Caspases (SMAC) Mimetic Debio 1143 When Given in Combination With Avelumab to Participants With Advanced Solid Malignancies and to Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Platinum-Based Therapy · 235 trials list this drug (51 active) | — | — | Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04150562Phase 2 · terminated Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma · 235 trials list this drug (51 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04561336Phase 2 · completed Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer · 235 trials list this drug (51 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074318Phase 1/Phase 2 · terminated Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery · 235 trials list this drug (51 active) | — | — | Liposarcoma,Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03000179Phase 2 · terminated Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma · 235 trials list this drug (51 active) | — | — | Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584829Phase 1/Phase 2 · terminated Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma · 235 trials list this drug (51 active) | — | — | Merkel Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03352934Phase 2 · completed Avelumab Treatment in Patients With Neuroendocrine Carcinomas (NEC G3) Progressive After Chemotherapy · 235 trials list this drug (51 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02493751Phase 1 · completed A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100) · 235 trials list this drug (51 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03035630Phase 2 · withdrawn Sunitinib Followed by Avelumab or the Reverse for Metastatic Renal Cell Carcinoma · 235 trials list this drug (51 active) | — | — | Kidney Neoplasm,Malignant Kidney Neoplasm,Clear Cell Renal Cell Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03637491Phase 1/Phase 2 · terminated A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors · 235 trials list this drug (51 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03514719Phase 1 · completed PD-L1 Imaging in Non Small Cell Lung Cancer' (PINNACLE) · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03341806Phase 1 · completed Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma · 235 trials list this drug (51 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01772004Phase 1 · completed Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor) · 235 trials list this drug (51 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03050814Phase 2 · terminated Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004 · 235 trials list this drug (51 active) | — | — | Colorectal Neoplasm,Colorectal Adenocarcinoma,Colorectal Carcinoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03158883early Phase 1 · completed UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04052204Phase 1/Phase 2 · terminated Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors · 235 trials list this drug (51 active) | — | — | Head and Neck Squamous Cell Carcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03439501Phase 2 · unknown Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY] · 235 trials list this drug (51 active) | — | — | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02952586Phase 3 · terminated Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) · 235 trials list this drug (51 active) | — | — | Head and Neck Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03800953Phase 2 · unknown The Ave-CRT Study for Newly Diagnosed Metastatic Esophageal Squamous Cell Carcinoma · 235 trials list this drug (51 active) | — | — | Esophageal Neoplasm,Esophageal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02349633Phase 1/Phase 2 · terminated Study For Patients With NSCLC EGFR Mutations (Del 19 or L858R +/- T790M) · 235 trials list this drug (51 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03910439Phase 2 · terminated Avelumab in Combination With Hypofractionated Radiotherapy in Patients With Relapsed Refractory Multiple Myeloma · 235 trials list this drug (51 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03563170Phase 1/Phase 2 · withdrawn QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine · 235 trials list this drug (51 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |